McElhaugh Michael J.

Insider profile

McElhaugh Michael J.'s trades of Arbutus Biopharma Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-04-21 2025-04-21 PrS Proposed sale
56,377
486.45
US$1,913,151
56,377 486.45 US$1,913,151
2025-04-15 2025-04-15 PrS Proposed sale
33,055
483.38
US$2,538,860
33,055 483.38 US$2,538,860
2025-02-05 2025-02-04 PlS Planned sale
51,630 -48.6%
287.96
US$1,471,796
51,630 -48.6% 287.96 US$1,471,796
2025-02-04 2025-02-04 PrS Proposed sale
23,790
3.28
US$78,103
23,790 3.28 US$78,103
2024-02-05 2024-02-02 PlS Planned sale
10,164 -0.7%
2.31
US$23,504
10,164 -0.7% 2.31 US$23,504
2021-02-10 2021-02-09 PlS Planned sale
20,000 -1.5%
5.00
US$100,000
20,000 -1.5% 5.00 US$100,000
2020-12-16 2020-12-14 PlS Planned sale
10,000 -0.7%
5.00
US$50,032
10,000 -0.7% 5.00 US$50,032
2020-12-16 2020-12-14 PlS Planned sale
30,000 -2.2%
5.00
US$150,000
30,000 -2.2% 5.00 US$150,000
2020-07-27 2020-07-23 PlS Planned sale
20,000 -1.4%
5.01
US$100,200
20,000 -1.4% 5.01 US$100,200